Write in a clean editor, then format for The Prostate Journal in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
The Prostate Journal is a peer-reviewed journal published by Wiley, covering Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies, Military Technology and Strategies.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." The Prostate Journal 12 (3): 45–58.
Formats any DOI in The Prostate Journal style. No sign-up. |
| Publishes research in | Legal and Regulatory Analysis Linguistic, Cultural, and Literary Studies Military Technology and Strategies Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment |
| ISSN | 1095-5100 |
| h-index | 9 |
| i10-index | 8 |
| Total citations | 315 |
| Top institutions publishing here | Dana-Farber Cancer Institute |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
ABSTRACT Objective: Vascular endothelial growth factor (VEGF) is a glycoprotein that is important in promoting tumor angiogenesis. Recombinant humanized anti (rhuMAb)‐VEGF is a humanized murine monoclonal antibody that neutralizes VEGF activity and has shown promise in animal tumor models. Methods: To evaluate the efficacy and safety of single‐agent rhuMAb VEGF in metastatic androgen‐independent prostate cancer…
ABSTRACT Objectives: Autopsy studies show that prostate cancer begins in the 4 th and 5 th decade of life. We sought to determine if increasing age at the time of diagnosis is related to morphologic and clinical predictors of cancer progression. Materials and Methods: We examined 7 morphologic variables known to impact progression of prostate…
ABSTRACT Objectives: Amplified in breast cancer‐1 (AIB1) is a steroid receptor coactivator that enhances estrogen‐dependent transcriptional activation by the estrogen receptor. It is unknown whether AIB1 also interacts with the androgen receptor. Because the development and progression of prostate cancer is likely to be partially mediated by steroid hormones, we investigated whether a polymorphic CAG/CAA…
ABSTRACT Objectives: Prostate cancer accounted for more than 180,000 new cases and almost 40,000 deaths in the United States in 1998. Higher rates of mortality have been noted among racial minorities and lower socioeconomic status groups, primarily because of advanced stage of cancer at presentation. Understanding barriers toward early detection of prostate cancer may help…
